Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
249.33 Thousand
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -15.87 |
| peg ratio | 0.70 |
| price to book ratio | 76.10 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -16.15 |
| price fair value | 76.10 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -352.13% |
| return on equity | -311.15% |
| return on capital employed | -475.16% |
liquidity ratios | |
|---|---|
| current ratio | 3.80 |
| quick ratio | 3.80 |
| cash ratio | 3.68 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 539.71 |
| cash conversion cycle | -539.71 |
| receivables turnover | 0.00 |
| payables turnover | 0.68 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.03 |
| interest coverage | -103,901.44 |
| cash flow to debt ratio | -50.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.37 |
| cash per share | 0.32 |
| operating cash flow per share | -0.37 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -50.04 |
| short term coverage ratios | -99.85 |
| capital expenditure coverage ratio | -522.23 |
Frequently Asked Questions
When was the last time Summit Therapeutics Inc. (NASDAQ:SMMT) reported earnings?
Summit Therapeutics Inc. (SMMT) published its most recent earnings results on 11-08-2025.
What is Summit Therapeutics Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Summit Therapeutics Inc. (NASDAQ:SMMT)'s trailing twelve months ROE is -311.15%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Summit Therapeutics Inc. (SMMT) currently has a ROA of -352.13%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SMMT's net profit margin stand at?
SMMT reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SMMT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.80 in the most recent quarter. The quick ratio stood at 3.80, with a Debt/Eq ratio of 0.03.